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Abstract
Biology has a conceptual basis that allows one to build models and theorize across many life
sciences, including medicine and medically-related disciplines. A dearth of good venues for
publication has been perceived during a period when bioinformatics, systems analysis and
biomathematics are burgeoning.
Steps have been taken to provide the sort of journal with a quick turnaround time for manuscripts
which is online and freely accessible to all readers, whatever their persuasion or discipline. We have
now been running for some time a journal which has had many good papers presented pre-launch,
and a steady stream of papers thereafter. The value of this journal as a new venue has already been
vindicated.
Within a short space of time, we have founded a state-of-the-art electronic journal freely accessible
to all in a much sort-after interdisciplinary field that will be of benefit to the thinking life scientist,
which must include medically qualified doctors as well as scientists who prefer to build their new
hypotheses on basic principles and sound concepts underpinning biology. At the same time, these
principles are not sacrosanct and require critical analysis. The journal http://www.tbiomed.com
promises to deliver many exciting ideas in the future.
Introduction
Several stories have been told about theorists; here are
two.
Two proponents of ideas from opposing schools of thought took
advice from a third party. To A he said she ought to listen to the
arguments propounded by B and not just dismiss them out of
hand; to B he said he should listen to the arguments of A and
not simply dismiss them. To them both, he said "I have been fair
with you both, since in all probability you are both wrong!"
The other story shows up the facileness of some arguments (or
their proponents): One day, Socrates was discussing Sod's law,
also well known in the world of the Ancient Greeks, who like us
all buttered their bread on one side. The law – also know as
Murphy's law – states that if dropped, the piece invariably lands
butter-side down. Next day one of his disciples came rushing to
him, remarking that at home in the evening he had buttered a
piece of bread, dropped it, and to his amazement it landed but-
ter-side up! Socrates thought for a moment before severely
rebuking him "you fool; you buttered the wrong side!"
How this new journal came about is an interesting story.
Continued dissatisfaction with other theoretical journals,
especially their slowness, and problems at Comments in
Theoretical Biology, were largely the precipitating factors. I
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also had colleagues at the Torino Politechnico supporting
me in the need for a vehicle to publish cancer modelling
problems as part of developing a European network of
excellence. This was reinforced by an editorial in Nature
[1] starkly pointing out the lack of a reasonable focus for
informatics on cancer and the need for a modeling forum,
at least in Europe, to help oncologists, but equally many
other scientists and doctors. Dr David Eagleman [2] made
a similar highly relevant point about theoretical science. I
suggested that the network of excellence we were striving
for in our European Consortium ought to have a web
presence, so why not have an online journal? That is why
I started one. Having undertaken primarily the role of
founding editor, my job was to get the journal up and run-
ning, and provide the editorial facilities. We have the
assured services of Dr Agutter and Ms Angela Panther as
managing editor and editorial officer, respectively, over-
seeing the smooth running of the journal on a daily basis.
Paul and I have published many papers in the field of the-
oretical biology and medicine, which are disseminated
over a wide range of journals that do not allow interested
parties to keep many of them easily in focus. Our experi-
ence in producing scientific papers as well as writing them
comes from a knowledge of e-publications, having one of
the first specialist (for which now read "independent")
journals to be published by BioMed Central (BMC)3
online,  viz. Cancer Cell International http://www.can
cerci.com
The nature of the journal
Speculation within limits, theorizing, and philosophizing
are part and parcel of biology and medicine, which are in
turn part of life. Having established certain facts or obser-
vations, we can employ deductive or inductive reasoning
depending on the number of such pieces of information –
as Bacon suggested – to reach certain tenuous conclu-
sions. From this position, we create hypotheses, the very
best being those that can be tested, not the unapproacha-
ble ones that will remain for ever. Biology has a broad cov-
erage, while medicine in contrast has a much narrower
focus, because its concepts must be the very same ones as
biology in general is built. These in turn have many of
their groundings in chemical and particularly physical
laws, but not all. The law of mass action cannot be applied
under the conditions of synthesis of a new molecule of
DNA. In addition to theorizing in medicine, we can also
build models that have clinical relevance to help us under-
stand such problems as the spread of diseases throughout
the body.
The opening up of bioinformatics, the proliferation of
databases on genes, proteins, metabolites and so on, have
created a climate in which many scientists can puddle to
their heart's content to make significant and meaningful
correlations. New ideas spring from some of these, just as
old ideas can find evidence suddenly becoming available
that was needed years ago to support them. Interdiscipli-
nary work is now highly fashionable; and mathematical
biology needs to become a force within biology, not a
peripheral, elitist activity. And so on; I rest my case.
The new journal on the web will consider high quality,
peer-reviewed theoretical papers. It will also seek to pro-
vide new ideas that may be quite off the main-stream of
biomedicine; after all, today's "crazy" notion has a not so
infrequently had the habit of becoming tomorrow's
received wisdom. My two colleagues, who are also Edi-
tors-in-Chief are Pier Paolo Delsanto in Turin and Hans-
Peter Meinzer in Heidelberg. The editorial board includes
many people well known to those who already publish in
theoretical journals.
The advantages of using the web, if not already self-evi-
dent, will become clear to you all once you appreciate
what a wonderfully interactive tool it affords. Debates on
papers can be posted along with referees' criticisms, if they
so choose. Commentaries can be put up online, much as
already done in BioMed Central's Journal of Biology. But we
also want theoretical work that is topical. Often editors
see no need to move theoretical papers quickly through
the publication process. Indeed, the only ones that get
held up even longer are papers dealing with the history of
biology, many of which often take years to complete the
acceptance and publication processes, my last one taking
very close to two years.
Many issues arise on which we are forced through incom-
plete knowledge to hypothesize about causes, such as the
spread of SARS. When SARS arose, ideas needed to be dis-
cussed as critically as possible, and an online journal has
almost a similar capacity to handle "copy" in the way that
newspaper handles it, although there is a world of differ-
ence between the editorial role of "Tbiomed" (our short-
ened title and URL name) and one in a tabloid newspaper
that is there to feed on drama, rumour and innuendo to
sell their products rather than on sound facts and rational
arguments. No one is selling anything in science, espe-
cially that which gets published and is accessible to every-
one free of charge online. So a theoretical journal that is
state- of-the-art emanating from BioMed Central offers
exactly what the doctor ordered, PhD or MD. I hope you
will make maximum use of it, and send papers that will
stir the thoughts of others.
We accept that there is the old thorny problem of impact
factors. My feeling is that no one scores heavily regarding
grant proposals from publishing a paper with your latest
and greatest hypothesis. The grant-awarding agencies pro-
vide funds for testing hypotheses, not formulating them.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
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Therefore in most cases publishing in Tbiomed is unlikely
to affect your street-credibility when it comes to grant pro-
posals; indeed it can help because the hypothesis you
want to test is out there online for all to read and explore.
The other issue is that impact factor continues to relate to
journal performance and not directly to the quality of the
individual  article. Because all new papers will soon be
completely accessible via the web, the paper itself can be
rated rather than the journal that holds it. An example of
this is Faculty of 1000, published by BioMed Central,
where experts can pick up and extol the virtues of an indi-
vidual paper, no matter in which journal it was published.
A call for papers
Our policy will be liberal, but we will not publish sub-
standard arguments, diatribes and purely rhetorical
pieces. Peer review will be strict, but we also will give
space to people with unconventional theories that have
been presented with sound logical reasoning. So here is a
call for papers:
So often we hear people say "...well, in theory, you may be
right!"
– so why not submit your hypotheses to one of BMC's newest
journals and find out what others think of them.
Advantages of publishing in Tbiomed
• Interactiveness
• Accessible to all
• No charges to authors from all BioMed Central sub-
scribing member institutions
• Presentation of complex equations and figures simple
and accurate
• Peer review criticisms can be published alongside arti-
cles
• Running commentaries can be made on published
papers
• No restriction on length, although brevity of expres-
sion will be sought
• Colour can be used as extensively as required
• Is a journal that forms a focus and interface for bioin-
formatics and multidisciplinary articles
• Topical matters requiring theoretical consideration
will be published quickly
• Juxtaposition of biology and medicine is intentional
to spawn more and better interactiveness
•  Articles can be accessed and disseminated freely,
meaning no reprint costs
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